NO20045304L - Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme - Google Patents

Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme

Info

Publication number
NO20045304L
NO20045304L NO20045304A NO20045304A NO20045304L NO 20045304 L NO20045304 L NO 20045304L NO 20045304 A NO20045304 A NO 20045304A NO 20045304 A NO20045304 A NO 20045304A NO 20045304 L NO20045304 L NO 20045304L
Authority
NO
Norway
Prior art keywords
substance
administration
fsh
amount equivalent
unit containing
Prior art date
Application number
NO20045304A
Other languages
English (en)
Norwegian (no)
Inventor
Herman Jan Tijmen Coel Bennink
Evert Johannes Bunschoten
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20045304L publication Critical patent/NO20045304L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20045304A 2002-06-07 2004-12-03 Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme NO20045304L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077221 2002-06-07
PCT/NL2003/000370 WO2003103770A2 (en) 2002-06-07 2003-06-06 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Publications (1)

Publication Number Publication Date
NO20045304L true NO20045304L (no) 2005-02-07

Family

ID=29724462

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045304A NO20045304L (no) 2002-06-07 2004-12-03 Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme

Country Status (21)

Country Link
US (1) US7815912B2 (ja)
EP (1) EP1511537B1 (ja)
JP (1) JP2005530818A (ja)
KR (1) KR20050058285A (ja)
CN (1) CN1684737A (ja)
AU (1) AU2003274929B2 (ja)
BR (1) BR0305033A (ja)
CA (1) CA2488719A1 (ja)
EA (1) EA009371B1 (ja)
ES (1) ES2399962T3 (ja)
IL (1) IL165522A0 (ja)
IS (1) IS7586A (ja)
ME (1) MEP39308A (ja)
MX (1) MXPA04012246A (ja)
NO (1) NO20045304L (ja)
NZ (1) NZ536984A (ja)
PL (1) PL373991A1 (ja)
RS (1) RS105004A (ja)
UA (1) UA81251C2 (ja)
WO (1) WO2003103770A2 (ja)
ZA (1) ZA200409857B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602008001783D1 (de) * 2007-01-08 2010-08-26 Pantarhei Bioscience Bv Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
WO2013010840A2 (en) * 2011-07-18 2013-01-24 Arts Biologics A/S Long acting biologically active luteinizing hormone (lh) compound
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
WO2018015497A2 (en) 2016-07-21 2018-01-25 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
CN114667141A (zh) 2019-09-03 2022-06-24 奥布赛瓦股份公司 用于促进胚胎移植和预防流产的催产素拮抗剂给药方案
US20230102503A1 (en) 2020-02-10 2023-03-30 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788799A3 (en) 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
CN1199642A (zh) * 1997-05-16 1998-11-25 Asta药物股份公司 治疗不育症的lhrh－拮抗剂
WO1998058657A1 (en) * 1997-06-20 1998-12-30 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
CZ301912B6 (cs) * 1998-04-23 2010-07-28 Zentaris Ivf Gmbh Lécivo na lécení neplodnosti nitrodeložní inseminací
EP1156822B1 (en) * 1999-02-24 2006-02-08 Novo Nordisk A/S Iin vitro method for synchronisation of oocyte maturation
US20030092628A1 (en) * 1999-06-23 2003-05-15 De Greef Henrik Johan Matthieu Maria Gonadotropin releasing hormone antagonist
JP2003503358A (ja) * 1999-06-23 2003-01-28 アクゾ・ノベル・エヌ・ベー ゴナドトロピン放出ホルモンのアンタゴニスト
KR20040032953A (ko) * 2001-09-12 2004-04-17 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 과배란 유도에서 ｌｈ의 용도
AU2002358346A1 (en) 2001-12-21 2003-07-15 Pantarhei Bioscience B.V. Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Also Published As

Publication number Publication date
ES2399962T3 (es) 2013-04-04
IL165522A0 (en) 2006-01-15
ZA200409857B (en) 2006-02-22
MEP39308A (en) 2011-02-10
UA81251C2 (en) 2007-12-25
CA2488719A1 (en) 2003-12-18
WO2003103770A3 (en) 2004-04-22
RS105004A (en) 2007-02-05
PL373991A1 (en) 2005-09-19
WO2003103770A2 (en) 2003-12-18
EA009371B1 (ru) 2007-12-28
IS7586A (is) 2004-12-03
NZ536984A (en) 2008-01-31
MXPA04012246A (es) 2005-04-08
EA200401619A1 (ru) 2005-06-30
EP1511537A2 (en) 2005-03-09
JP2005530818A (ja) 2005-10-13
BR0305033A (pt) 2004-11-09
EP1511537B1 (en) 2012-11-21
AU2003274929A1 (en) 2003-12-22
AU2003274929B2 (en) 2008-04-10
US20050235374A1 (en) 2005-10-20
CN1684737A (zh) 2005-10-19
KR20050058285A (ko) 2005-06-16
US7815912B2 (en) 2010-10-19

Similar Documents

Publication Publication Date Title
Schally et al. LH‐RH agonists and antagonists
Sharoni et al. Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone.
Lin et al. Effects of [d-Arg6, Trp7, Leu8, Pro9 NEt]-luteinizing hormone-releasing hormone (sGnRH-A) and [d-Ala6, Pro9NEt]-luteinizing hormone-releasing hormone (LHRH-A), in combination with pimozide or domperidone, on Gonadotropin release and ovulation in the Chinese loach and common carp
Sahu et al. Dynamic changes in neuropeptide Y concentrations in the median eminence in association with preovulatory luteinizing hormone release in the rat
DE69927705T2 (de) Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen-gonadenachse
AU2002310788B2 (en) Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
NO20045304L (no) Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme
Corbin et al. Peptide Contraception: Antifertility Properties of LH‐RH Analogues
Buckingham et al. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat
Neidhart Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion
Volkmann et al. Failure of hCG to support luteal function in bitches after estrus induction using deslorelin implants
RU2181598C2 (ru) Восстановление тонической секреции эстрогена из яичников для продолжительных схем лечения
PT1425033E (pt) Utilização de hcg e lh na hiper-estimulação controlada dos ovários
US20210137923A1 (en) Treatment of sexual dysfunction
Kasting et al. Endogenous prostaglandins affect growth hormone and thyrotropin release at a hypothalamic, not a pituitary level
ADELSON et al. Effects of gonadotropin-releasing hormone analogues on ovarian epithelial tumors
US20120004182A1 (en) Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells
CA2472309A1 (en) Multiple dose aromatase inhibitor for treating infertility
KR20030051828A (ko) 에스트로겐 의존성 질환의 병용 치료법
Omi et al. Evidence that systemic relaxin promotes moderate water consumption during late pregnancy in rats
CA2444980A1 (en) Single dose aromatase inhibitor for treating infertility
Mouanness et al. Elagolix Represents a Less Invasive and Cheaper Option Than Injectable GnRH Antagonist for Ovulation Suppression in IVF
CN111295192A (zh) 用于前列腺癌治疗的辅助疗法
And et al. Effects of oral and intravenous TRH and metoclopramide on PRL and TSH secretion in women
Hammond et al. Diagnostic and therapeutic uses of gonadotropin-releasing hormone

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application